Application 078796
- Type
- ANDA
- Sponsor
- HOSPIRA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | IRINOTECAN HYDROCHLORIDE | IRINOTECAN HYDROCHLORIDE | INJECTABLE;INJECTION | 500MG/25ML (20MG/ML) | No | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A078796-001 | IRINOTECAN HYDROCHLORIDE | IRINOTECAN HYDROCHLORIDE | 500MG/25ML (20MG/ML) | INJECTABLE / INJECTION | AP | RS | 2008-02-27 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A078796-001 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A078796-001 | IRINOTECAN HYDROCHLORIDE | 500MG/25ML (20MG/ML) | INJECTABLE / INJECTION | AP | RS | 2008-02-27 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A078796-001 | AP | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Camptosar | IRINOTECAN HYDROCHLORIDE | Pharmacia & Upjohn Company LLC | e518dfc6-7e93-4fee-a66c-51e1ab71c056 | 2026-05-12 | Boxed warning, Warnings, Adverse reactions | IRINOTECAN HYDROCHLORIDE |
| Irinotecan Hydrochloride | IRINOTECAN HYDROCHLORIDE | Ingenus Pharmaceuticals, LLC | d04f2471-3085-4fc8-a657-bb3918d48e6e | 2026-03-07 | Boxed warning, Warnings, Adverse reactions | Irinotecan Hydrochloride IRINOTECAN HYDROCHLORIDE |
| Irinotecan hydrochloide | IRINOTECAN HYDROCHLOIDE | Xiromed LLC | b26e5d27-dba5-7538-9e7b-48b358998cbb | 2026-02-19 | Boxed warning, Warnings, Adverse reactions | Irinotecan hydrochloride IRINOTECAN HYDROCHLORIDE |
| Irinotecan Hydrochloride | IRINOTECAN HYDROCHLORIDE | Sagent Pharmaceuticals | caab50e6-0dad-4ddd-9a6c-96cc2b87aee7 | 2026-02-06 | Boxed warning, Warnings, Adverse reactions | Irinotecan Hydrochloride IRINOTECAN HYDROCHLORIDE |
| Irinotecan Hydrochloride | IRINOTECAN HYDROCHLORIDE | Hospira, Inc. | 5c527c2e-9062-4afe-dbbb-f650db3a340f | 2025-11-03 | Boxed warning, Warnings, Adverse reactions | Irinotecan Hydrochloride IRINOTECAN HYDROCHLORIDE |
| IRINOTECAN HYDROCHLORIDE | IRINOTECAN HYDROCHLORIDE | Eugia US LLC | 7a30d551-9ea7-47ea-9073-f541bff457a3 | 2025-06-05 | Boxed warning, Warnings, Adverse reactions | IRINOTECAN HYDROCHLORIDE IRINOTECAN HYDROCHLORIDE |
| Irinotecan hydrochloride | IRINOTECAN HYDROCHLORIDE | Actavis Pharma, Inc. | 5e1fdcaa-918f-4cd8-9c7a-4c538d866198 | 2025-05-31 | Boxed warning, Warnings, Adverse reactions | Irinotecan hydrochloride IRINOTECAN HYDROCHLORIDE |
| Onivyde | IRINOTECAN HYDROCHLORIDE | Ipsen Biopharmaceuticals, Inc. | c8b58efa-1820-48a4-b70d-62918fc4abfc | 2025-03-03 | Boxed warning, Warnings, Adverse reactions | IRINOTECAN HYDROCHLORIDE |
| Irinotecan Hydrochloride | IRINOTECAN HYDROCHLORIDE | Apotex Corp. | 8fe98987-e526-4729-a8f4-c7230f424108 | 2024-07-04 | Boxed warning, Warnings, Adverse reactions | Irinotecan Hydrochloride IRINOTECAN HYDROCHLORIDE |
| Irinotecan Hydrochloride | IRINOTECAN HYDROCHLORIDE | Apotex Corp. | 85ed6019-f462-4abe-a89e-ad991623c86d | 2024-06-28 | Boxed warning, Warnings, Adverse reactions | Irinotecan Hydrochloride IRINOTECAN HYDROCHLORIDE |
| Irinotecan Hydrochloride | IRINOTECAN HYDROCHLORIDE | Fresenius Kabi USA, LLC | ee45f127-8450-4455-a945-a1f5707f1d39 | 2023-01-19 | Boxed warning, Warnings, Adverse reactions | Irinotecan Hydrochloride IRINOTECAN HYDROCHLORIDE |
| Irinotecan hydrochloride | IRINOTECAN HYDROCHLORIDE | Northstar Rx LLC | 4f98e9ed-f7b1-5346-af72-fccb0abf3f4b | 2022-03-31 | Boxed warning, Warnings, Adverse reactions | Irinotecan hydrochloride IRINOTECAN HYDROCHLORIDE |
| Irinotecan hydrochloide | IRINOTECAN HYDROCHLOIDE | Gland Pharma Limited | de634e80-328a-4473-b395-0172683a2411 | 2022-03-03 | Boxed warning, Warnings, Adverse reactions | Irinotecan hydrochloride IRINOTECAN HYDROCHLORIDE |
| Irinotecan Hydrochloride | IRINOTECAN HYDROCHLORIDE | Qilu Pharmaceutical Co., Ltd. | afcdde49-ec0c-4c56-a1af-2917185b1a08 | 2021-03-10 | Boxed warning, Warnings, Adverse reactions | Irinotecan Hydrochloride IRINOTECAN HYDROCHLORIDE |
| Irinotecan Hydrochloride | IRINOTECAN HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | 9c6aa884-750e-4b11-9955-bc7ab6e9c2ad | 2020-06-28 | Boxed warning, Warnings, Adverse reactions | Irinotecan Hydrochloride IRINOTECAN HYDROCHLORIDE |
| Irinotecan Hydrochloride | IRINOTECAN HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | be716692-6b4f-47b6-83d1-01665861626b | 2020-06-23 | Boxed warning, Warnings, Adverse reactions | Irinotecan Hydrochloride IRINOTECAN HYDROCHLORIDE |